Vanda Pharmaceuticals
VNDA
VNDA
149 hedge funds and large institutions have $369M invested in Vanda Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 62 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
5.22% less ownership
Funds ownership: 76% → 70.79% (-5.2%)
37% less repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 62
Holders
149
Holding in Top 10
2
Calls
$10.5M
Puts
$1.04M
Top Buyers
| 1 | +$11M | |
| 2 | +$3.3M | |
| 3 | +$1.93M | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$1.85M |
| 5 |
Two Sigma Investments
New York
|
+$1.74M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$8.65M | |
| 3 | -$6.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.45M |
